Bank of New York Mellon’s LIBERATOR MED HLDGS INC (NY) LBMH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-231,803
Closed -$774K 4384
2015
Q4
$774K Sell
231,803
-100,079
-30% -$291K ﹤0.01% 3320
2015
Q3
$780K Buy
331,882
+1,501
+0.5% +$3.61K ﹤0.01% 3338
2015
Q2
$750K Sell
330,381
-78,259
-19% -$227K ﹤0.01% 3484
2015
Q1
$1.43M Buy
408,640
+35,058
+9% +$120K ﹤0.01% 3089
2014
Q4
$1.08M Buy
373,582
+248,189
+198% +$700K ﹤0.01% 3256
2014
Q3
$393K Sell
125,393
-189
-0.2% -$597 ﹤0.01% 3706
2014
Q2
$471K Buy
125,582
+87,821
+233% +$341K ﹤0.01% 3628
2014
Q1
$148K Hold
37,761
﹤0.01% 3915
2013
Q4
$157K Buy
+37,761
New +$140K ﹤0.01% 3910

Bank of New York Mellon's LBMH Position: Q1 2016 in Review

Bank of New York Mellon sold out of LIBERATOR MED HLDGS INC (NY) (LBMH) in Q1 2016, closing a stake of 231,803 shares — an estimated $774K sold.

Bank of New York Mellon first reported a position in LBMH in Q4 2013 and held it in 9 quarters. The position peaked at $1.43M in Q1 2015. 0 funds tracked by Wall St. Rank hold LBMH as of Q1 2016.

  • Bank of New York Mellon reported no remaining LIBERATOR MED HLDGS INC (NY) position as of Q1 2016 after selling out during the quarter.
  • Bank of New York Mellon sold 231,803 LIBERATOR MED HLDGS INC (NY) shares in Q1 2016, an estimated $774K.
  • Bank of New York Mellon first reported a position in LIBERATOR MED HLDGS INC (NY) in Q4 2013 and held it in 9 quarters.
  • Bank of New York Mellon's LIBERATOR MED HLDGS INC (NY) position peaked at $1.43M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held LIBERATOR MED HLDGS INC (NY) as of Q1 2016.

Based on Bank of New York Mellon's 13F filing for Q1 2016, filed 11 May 2016.